Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JS005 in active ankylosing spondylitis (Phase II, China)
CTR20212392Phase 2Completed
- Sponsor
- Shanghai Junshi Biosciences Co., Ltd.
- Start
- Sep 2021
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of roconkibart in ankylosing spondylitis (AS), sponsored by Shanghai Junshi Biosciences Co., Ltd.. Started Sep 2021; status: completed.
02
Drugs
roconkibart
03
Conditions
ankylosing spondylitis (AS)
Beyond the preview
Go deeper on CTR20212392.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20212392.